Pharma Promotion / Incidents by company / UCB
UCB
4 incidents / jurisdictions: European Union, United States / sum of amounts reported: EUR 10.4 m / USD 68.0 m
| Date | Jurisdiction | Outcome | What happened (source) | Damages / settlement / fine |
|---|---|---|---|---|
| 2020-08-17 | United States | Filed / under investigation | United States v. UCB, Inc. Court of Appeals for the Seventh Circuit + 2 more reports | — |
| 2011-06-09 | United States | Guilty plea / conviction | U.S. Subsidiary of Belgian Pharmaceutical Manufacturer Pleads Guilty to Off-Label Promotion; Company to Pay More Than $34 Million U.S. Department of Justice | $34 Million |
| 2004 | European Union | Fine / administrative sanction | In 2004, UCB was fined €10.4 million by the EU for its involvement in a vitamin B4 price fixing cartel. In 2011, UCB was fined $34 million in the US for fraud arising from the mispromotion of Keppra f Wikipedia: UCB (company)（Scandals） | €10.4 million / $34 million |
| 1999-09-29 | United States | Other | Schering Corporation v. Pfizer Inc. And Ucb Pharma, Inc. Court of Appeals for the Second Circuit | — |
Amounts are extracted mechanically from headlines and summaries and kept only when Jev confirms they are paid by the company. The same case reported by several articles may be counted more than once, so totals are indicative. Check the sources.